Terri-Ann Samuels
Urogynecology and Reconstructive Pelvic Surgery · Bellaire, TXNPI 1275717431
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Coloplast at 28.2% of the total.
Across 151 payments — averaging $59.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$3K
- Medtronic$2K
- Escala Medical Inc.$1K
- Boston Scientific$772
- Axonics, Inc.$395
- Femselect Inc.$356
- plus $1K from 19 others
Across 25 payments — averaging $1014.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$25K
What the payments were for
- Travel & lodging$3,94644%
- Food & beverage$4,83754%
- Education$2142%
- Gifts$380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 17 | $2,547 |
| Medtronic(2 entities) | 58 | $2,328 |
| Escala Medical Inc. | 2 | $1,498 |
| Boston Scientific | 9 | $772 |
| Axonics, Inc. | 9 | $395 |
| Femselect Inc. | 2 | $356 |
| Caldera Medical, Inc | 5 | $236 |
| AbbVie(2 entities) | 13 | $232 |
| Lupin Inc. | 10 | $141 |
| Intuitive Surgical | 4 | $95 |
| Astellas Pharma US Inc | 5 | $85 |
| Amgen | 3 | $52 |
| Mayne Pharma Commercial LLC | 1 | $44 |
| Pfizer | 2 | $35 |
| Valencia Technologies Corporation | 1 | $27 |
| Contura, Inc. | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Bayer | 1 | $22 |
| Aspira Women's Health Inc | 1 | $20 |
| Evofem Biosciences, Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
| Therapeuticsmd, Inc. | 1 | $16 |
| Abbott | 1 | $16 |
| Coopersurgical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$1,911
- INTERSTIM$1,267
- EnPlace$356
- Solyx SIS System$259
- RESTORELLE$148
- Advantage System$120
- GENERAL FEMALE SUI$120
- SOLYX$110
- Axonics$106
How this compares
$9,035 in reported general payments places this provider in the 70th percentile of 74 urogynecology and reconstructive pelvic surgery providers in Texas.
See all urogynecology and reconstructive pelvic surgery providers in Texas →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 12 | $10,613 |
| Np ThyroidThyroid,pork | 13 | $862 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $118 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Bellaire
- Stephen KrausSan Antonio$372K
- Keith XavierArlington$282K
- Tomas AntoniniAustin$183K
- Amanda WhiteAustin$108K
- Gazala SiddiquiHouston$81K
- Fiona LindoHouston$66K
- Peter LotzeHouston$48K
- Tracy Cannon-SmithArlington$29K
- Teresa IrwinSan Marcos$20K
- Oluwarotimi NetteyHouston$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.